Immunic
IMUX
IMUX
55 hedge funds and large institutions have $35M invested in Immunic in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $44.1M → $35M (-$9.09M)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Holders
55
Holding in Top 10
–
Calls
$161K
Puts
$14K
Top Buyers
| 1 | +$5.01M | |
| 2 | +$2.13M | |
| 3 | +$1.17M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$810K |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$582K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$872K | |
| 3 | -$584K | |
| 4 |
Renaissance Technologies
New York
|
-$375K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$359K |
